Account
FundsIndia.com appoints Dentsu as creative partner
MUMBAI: Following a multi-agency pitch, Dentsu India has bagged the strategic and creative mandate for FundsIndia – India’s friendliest investment platform.
FundsIndia offers investment advice and solutions across a wide-range of products like mutual funds, stocks, corporate fixed deposits and more. It brings together cutting-edge technology and financial expertise in a powerful combination that allows customers to manage their investments and get help anytime, anywhere.
FundsIndia co-founder and CEO, C R Chandrasekar, said, “Team Dentsu India impressed us with their deep consumer insights and their ability to craft simple and crisp messaging. The team also demonstrated a strong understanding of underlying media RoI. This can be of immense help in performance-marketing for brands such as ours.”
FundsIndia co-founder and COO Srikanth Meenakshi, said, “At FundsIndia, we are fundamentally changing the way Indians save and invest for their future.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
